Nonrandomized comparison of neurofibromatosis type 1 and non–neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low‐grade glioma: A report from the Children's Oncology GroupJoann L. Ater, Ian F. Pollack, Richard Sposto et al.|Cancer|2016Cited by 121